• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    1.46 Up 0.06(4.29%) Aug 28, 4:03PM EDT
    Add to Portfolio
    Prev Close:1.40
    Open:1.43
    Bid:1.47 x 500
    Ask:1.48 x 4200
    1y Target Est:2.60
    Beta:-0.358376
    Earnings Date:Nov 11 - Nov 18 (Est.)
    Day's Range:1.40 - 1.48
    52wk Range:1.33 - 3.00
    Volume:24,716
    Avg Vol (3m):174,255
    Market Cap:136.90M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PLX

    Comparison

    Symbol% ChgMkt Cap
    PLXUp 4.29%136.90M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.31
    Quarterly EPS Est (Sep-15) :-0.07
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):-0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback